BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang XH, Wang XY, Zhou ZW, Bai H, Shi L, Yang YX, Zhou SF, Zhang XC. The combination of digoxin and GSK2606414 exerts synergistic anticancer activity against leukemia in vitro and in vivo. Biofactors 2017;43:812-20. [PMID: 28817203 DOI: 10.1002/biof.1380] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Shacham T, Patel C, Lederkremer GZ. PERK Pathway and Neurodegenerative Disease: To Inhibit or to Activate? Biomolecules 2021;11:354. [PMID: 33652720 DOI: 10.3390/biom11030354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
2 Parreira GM, Faria JA, Marques SMS, Garcia IJP, Silva IF, De Carvalho LED, Villar JAFP, Machado MV, de Castro Lima M, Barbosa LA, Cortes VF, de Lima Santos H. The γ-Benzylidene Digoxin Derivative BD-15 Increases the α3-Na, K-ATPase Activity in Rat Hippocampus and Prefrontal Cortex and no Change on Heart. J Membr Biol 2021;254:189-99. [PMID: 33598793 DOI: 10.1007/s00232-021-00173-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Féral K, Jaud M, Philippe C, Di Bella D, Pyronnet S, Rouault-Pierre K, Mazzolini L, Touriol C. ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both? Biomolecules 2021;11:199. [PMID: 33573353 DOI: 10.3390/biom11020199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
4 Pourakbari R, Taher SM, Mosayyebi B, Ayoubi-Joshaghani MH, Ahmadi H, Aghebati-Maleki L. Implications for glycosylated compounds and their anti-cancer effects. Int J Biol Macromol 2020;163:1323-32. [PMID: 32622770 DOI: 10.1016/j.ijbiomac.2020.06.281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
5 Huelse JM, Fridlyand DM, Earp S, DeRyckere D, Graham DK. MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system. Pharmacol Ther 2020;213:107577. [PMID: 32417270 DOI: 10.1016/j.pharmthera.2020.107577] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
6 Wang Y, Ma Q, Zhang S, Liu H, Zhao B, Du B, Wang W, Lin P, Zhang Z, Zhong Y, Kong D. Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin. Front Pharmacol 2020;11:186. [PMID: 32180730 DOI: 10.3389/fphar.2020.00186] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
7 Yokoyama S, Sugimoto Y, Nakagawa C, Hosomi K, Takada M. Integrative analysis of clinical and bioinformatics databases to identify anticancer properties of digoxin. Sci Rep 2019;9:16597. [PMID: 31719612 DOI: 10.1038/s41598-019-53392-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Ren Y, de Blanco EJC, Fuchs JR, Soejarto DD, Burdette JE, Swanson SM, Kinghorn AD. Potential Anticancer Agents Characterized from Selected Tropical Plants. J Nat Prod 2019;82:657-79. [PMID: 30830783 DOI: 10.1021/acs.jnatprod.9b00018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 33] [Article Influence: 6.7] [Reference Citation Analysis]
9 El-Seedi HR, Khalifa SAM, Taher EA, Farag MA, Saeed A, Gamal M, Hegazy MF, Youssef D, Musharraf SG, Alajlani MM, Xiao J, Efferth T. Cardenolides: Insights from chemical structure and pharmacological utility. Pharmacol Res 2019;141:123-75. [PMID: 30579976 DOI: 10.1016/j.phrs.2018.12.015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]